Kprx stock price.

Find the latest Dragonfly Energy Holdings Corp. (DFLI) stock quote, history, news and other vital information to help you with your stock trading and investing.Jun 2, 2023 · Kiora Pharmaceuticals (KPRX) stock dropped 50% on Friday after the firm priced an underwritten public offering for gross proceeds of ~$5.5M.The offering is comprised of ~1.4M shares,... Kiora Pharmaceuticals Stock Chart and Share Price Forecast, Short-Term "KPRX" Stock Prediction for Next Days and Weeks Walletinvestor.com Kiora Pharmaceuticals Inc (KPRX) Forecast Chart, Long-Term Predictions for Next Months and Year: 2023, 2024 Earnings results from Amgen (AMGN), Gilead (GILD) and others are the key highlights from the biotech sector during the past week. Find the latest Kiora Pharmaceuticals, Inc. (KPRX) stock quote, history, news and other vital information to help you with your stock trading and investing.

Mar 24, 2023 · 0. 0. According to 4 analyst offering 12-month price targets in the last 3 months, Kiora Pharmaceuticals has an average price target of $36.75 with a high of $119.00 and a low of $6.00. Below is a ... The 3 analysts offering 1 year price forecasts for KPRX have a max estimate of — and a min estimate of —. Analyst rating Based on 3 analysts giving stock ratings to KPRX in the past 3 months.

Feb 10, 2023 ... ... price targets on the company's stock and three raising them. ... Kiora Pharmaceuticals (KPRX) shares zoomed 109% this week from $3.28 on Monday ...Kiora Pharmaceuticals Inc’s trailing 12-month revenue is $0.0 million with a % profit margin. Year-over-year quarterly sales growth most recently was %. Analysts expect adjusted earnings to reach $-1.740 per share for the current fiscal year. Kiora Pharmaceuticals Inc does not currently pay a dividend.

Dec 1, 2023 · Kiora Pharmaceuticals Inc’s trailing 12-month revenue is $0.0 million with a % profit margin. Year-over-year quarterly sales growth most recently was %. Analysts expect adjusted earnings to reach $-1.740 per share for the current fiscal year. Kiora Pharmaceuticals Inc does not currently pay a dividend. In today’s recent session, 1.34 million shares of the Kiora Pharmaceuticals Inc (NASDAQ:KPRX) have been traded, and its beta is -0.26. Most recently the company’s share price was $0.61, and it changed around -$0.01 or -1.53% from the last close, which brings the market valuation of the company to $4.43M. KPRX at last check was trading at a ...Kiora Pharmaceuticals, Inc. is a clinical-stage pharmaceutical company. The Company is focused on developing and commercializing therapies for the treatment of ophthalmic diseases. Its pipeline consists of three product candidates, including KIO-101, KIO-301, and KIO-201. Its lead product, KIO-301, is a potential vision-restoring small molecule ...KPRX Stock 12 Months Forecast. $2.75. (347.15% Upside) Based on 2 Wall Street analysts offering 12 month price targets for Kiora Pharmaceuticals in the last 3 months. The average price target is $2.75 with a high forecast of $3.50 and a low forecast of $2.00. The average price target represents a 347.15% change from the last price of $0.62.

Kiora Pharmaceuticals (KPRX) Stock Forecast & Price Target $0.51 -0.04 (-7.30%) (As of 11/27/2023 ET) Compare Today's Range $0.51 $0.52 50-Day Range $0.51 …

With Kiora Pharmaceuticals stock trading at $0.53 per share, the total value of Kiora Pharmaceuticals stock (market capitalization) is $4.07M. Kiora Pharmaceuticals stock was originally listed at a price of $3,600.00 in Feb 13, 2015.

A. The latest price target for Hoth Therapeutics ( NASDAQ: HOTH) was reported by EF Hutton on Thursday, September 14, 2023. The analyst firm set a price target for 7.50 expecting HOTH to rise to ...KPRX Overview Stock Screener Earnings Calendar Sectors Nasdaq | KPRX U.S.: Nasdaq Kiora Pharmaceuticals Inc. Watch list NEW Set a price target alert Open Last Updated: …Find the latest CymaBay Therapeutics, Inc. (CBAY) stock quote, history, news and other vital information to help you with your stock trading and investing.The average Palisade Bio stock price prediction forecasts a potential upside of 156.41% from the current PALI share price of $0.59. What is PALI's forecast return on assets (ROA) for 2023-2023? (NASDAQ: PALI) forecast ROA is -378.04%, which is lower than the forecast US Biotechnology industry average of -5.67%.Nov 30, 2023 · The latest price target for Kiora Pharmaceuticals ( NASDAQ: KPRX) was reported by HC Wainwright & Co. on Monday, November 13, 2023. The analyst firm set a price target for 3.50 expecting KPRX to ... The average twelve-month price prediction for Catalyst Pharmaceuticals is $24.75 with a high price target of $27.00 and a low price target of $24.00. Learn more on CPRX's analyst rating history. Do Wall Street analysts like Catalyst Pharmaceuticals more than its competitors? Analysts like Catalyst Pharmaceuticals more than other Medical companies.

The 3 analysts offering 1 year price forecasts for KPRX have a max estimate of — and a min estimate of —. Analyst rating Based on 3 analysts giving stock ratings to KPRX in the past 3 months. The Kiora Pharmaceuticals, Inc. stock price forecast for the next 30 days is a projection based on the positive/negative trends in the past 30 days. Based on the current trend the price of KPRX stock is predicted to rise by 0.82% tomorrow and lose -1.08% in the next 7 days. Target Price: 12.83: Perf Year-85.98%: Cash/sh: 0.70: P/C: 0.72: EPS next 5Y-ROE-136.84%: 52W Range: 0.46 - 8.52: Perf YTD-85.28%: Dividend-P/FCF-EPS past 5Y: …Who Owns Kiora Pharmaceuticals, Inc. (KPRX) Kiora Pharmaceuticals, Inc. (KPRX) is a publicly traded company, meaning that its ownership is spread across a large number of shareholders who own the company's stock. The largest shareholders of Kiora Pharmaceuticals, Inc. are institutional investors, such as mutual funds, pension funds, …On August 1, 2022, the stock started to rise incredibly fast and, despite the lack of a catalyst, surged from its IPO price to $721.23, a 21,000% increase, resulting in a market capitalization of over $310 billion. It put AMTD Digital's market capitalization higher than companies like Bank of America, Coca-Cola, Shell and Costco.

KPRX’s Market Performance. The stock of Kiora Pharmaceuticals Inc (KPRX) has seen a 11.98% increase in the past week, with a 9.98% rise in the past month, and a 19.87% gain in the past quarter. The volatility ratio for the week is 4.03%, and the volatility levels for the past 30 days are at 5.80% for KPRX. The simple moving average for the ...The Kiora Pharmaceuticals Inc (KPRX) stock price forecast for the next 12 months is generally positive, with an average analyst price target of $28.38, representing a +5,060% increase from the current price of $0.55. The highest analyst price target is $35.44, and the lowest is $21.32.

Stock analysis for Kiora Pharmaceuticals Inc (KPRX:NASDAQ CM) including stock price, stock chart, company news, key statistics, fundamentals and …Kiora Pharmaceuticals, Inc. (KPRX) is a biopharmaceutical company that develops treatments for inherited retinal diseases. The stock price, news, quote and history of KPRX are shown on Yahoo Finance. See the latest performance outlook, earnings date, dividend yield, research reports and more. KPRX is a biotechnology company that develops and commercializes therapies for ophthalmic diseases. The stock price, quote, news, and analysis of KPRX …SONX | Complete Sonendo Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.Jul 21, 2023 · The problem with KPRX stock is that its shares have remained below the $1 minimum bid price for 30 consecutive business days. According to this filing, Kiora Pharmaceuticals now has 180 days to ... Kiora Pharmaceuticals (KPRX) Stock Price, Quote, News & Analysis - TipRanks.com. Analyst ForecastsNews & Insights. TipRanks is a comprehensive research tool that helps investors make better, data-driven investment decisions. Kiora Pharmaceuticals (KPRX) has a Smart Score of N/A based on an analysis of 8 unique data sets, including Analyst ...Monday, November 06, 2023 6:59:06 AM. Post # of 26822. KPRX - .6201 Pre-market at .695/.70. Kiora Pharmaceuticals Announced Topline Results Of Its Phase 1/2 Trial Demonstrating Proof-of-concept That KIO-301 Has The Potential To Meaningfully Improve Vision In Patients With Retinitis Pigmentosa With Ultra-low Vision Or Complete …Nov 27, 2023 · Stock Price Forecast. According to 3 stock analysts, the average 12-month stock price forecast for KPRX stock stock is $41.5, which predicts an increase of 7,117.39%. The lowest target is $2.00 and the highest is $119. On average, analysts rate KPRX stock stock as a strong buy. Kiora Pharmaceuticals Inc (KPRX) Message Board - Company Name: Kiora Pharmaceuticals Inc, Stock Symbol: KPRX, Industry: Biotechs - Total Posts: 45 - Last Post: 08/31/2023 03:21:18 PM - company/specific stock boardFeb 7, 2023 ... ... stock price. Economic Trends and Government Policies. In addition to ... KPRX Stock News. This week's headlines focus on KIO-101 and a related ...

Feb 7, 2023 ... ... stock price. Economic Trends and Government Policies. In addition to ... KPRX Stock News. This week's headlines focus on KIO-101 and a related ...

Kiora Pharmaceuticals, Inc. Common Stock (KPRX) After-Hours Stock Quotes - Nasdaq offers after-hours quotes and extended trading activity data for US and global markets.

Dec 1, 2023 · Kiora Pharmaceuticals last announced its quarterly earnings results on November 9th, 2023. The reported ($0.89) earnings per share for the quarter, missing analysts' consensus estimates of ($0.30) by $0.59. Kiora Pharmaceuticals has generated $0.00 earnings per share over the last year. Nov 30, 2023 · Analyst Forecast. According to 3 analysts, the average rating for KPRX stock is "Strong Buy." The 12-month stock price forecast is $41.5, which is an increase of 8,122.71% from the latest price. Kiora Pharmaceuticals Inc’s trailing 12-month revenue is $0.0 million with a % profit margin. Year-over-year quarterly sales growth most recently was %. Analysts expect adjusted earnings to reach $-1.740 per share for the current fiscal year. Kiora Pharmaceuticals Inc does not currently pay a dividend.Find the latest Phillips 66 (PSX) stock quote, history, news and other vital information to help you with your stock trading and investing.Nov 20, 2023 ... So, for instance, a stock could have a price-to-book ranking in the ... KPRX, Industry Median. Price/Sales, na, na, 2.32. Price/Earnings, na, na ...Find the latest Cognizant Technology Solutions Corporation (CTSH) stock quote, history, news and other vital information to help you with your stock trading and investing.Get the latest Walt Disney Co (DIS) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions.As at 01.12.23 17:56:43 GMT - All data delayed at least 15 minutes. Search for stocks and share prices, company fundamentals, news and trading information for all instruments traded on the London Stock Exchange's markets via Company, Code, ISIN, Carket, Instrument type, Sector and Admission date.On November 13, 2023, New Fortress Energy Inc (NFE) had a median target price of $44.00, according to the 12-month price forecasts provided by nine analysts. The high estimate was $60.00, while the low estimate was $32.00. This indicates a potential increase of 29.99% from the last recorded price of $33.85.Webull offers KIORA PHARMACEUTICALS INC (KPRX) historical stock prices, in-depth market analysis, NASDAQ: KPRX real-time stock quote data, in-depth charts.Nov 10, 2023 · H.C. Wainwright Sticks to Their Buy Rating for Kiora Pharmaceuticals (KPRX) August 24, 2023TipRanks. Kiora Pharmaceuticals price target lowered to $2 from $7 at H.C. Wainwright August 14 ... What are the best stocks to buy? Learn how you can make that decision for yourself at InvestorPlace. With the help of experienced financial advisors, InvestorPlace can give you the info you need to form an effective investment strategy. So ...

According to 3 analysts, the average rating for KPRX stock is "Strong Buy." The 12-month stock price forecast is $41.5, which is an increase of 8,122.71% from the latest price. Price TargetThe Kiora Pharmaceuticals 52-week high stock price is 8.52, which is 1421.4% above the current share price. The Kiora Pharmaceuticals 52-week low stock price is 0.46, which is 17.9% below the current share price. The average Kiora Pharmaceuticals stock price for the last 52 weeks is 2.18. For more information on how our historical price data is ...KPRX Latest After Hours Trades. Select time range to see more trades: Last 100 Trades. After Hours Time (ET) After Hours Price. After Hours Share Volume. 19:59:42. $6.39. 4.Instagram:https://instagram. k1 filingtop mobile banking appsodte optionsutg dividend News Ideas Financials Technicals Forecast KPRX chart Today −0.69% 5 days −7.26% 1 month −4.17% 6 months −72.49% Year to date −83.43% 1 year −91.21% 5 years … yieldmax fundsvti holdings Virpax Pharmaceuticals (VRPX) said it signed a cooperative research and development agreement ((CRADA)) with the U.S quarter worth Mar 1, 2022 ... One thing to consider is that the analyst outlook remains optimistic with the current pipeline. Maxim Group initiated coverage on KPRX stock ...Find the latest Getty Images Holdings, Inc. (GETY) stock quote, history, news and other vital information to help you with your stock trading and investing.It’s also priced below the stock’s $1.66 closing price on Thursday, which doesn’t help matters. With today’s stock offering news comes heavy trading of KPRX stock. As of this writing, more ...